Format
Sort by

Send to

Choose Destination

Selected items

Items: 9

1.

Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.

Shojaei MH, Djalali M, Siassi F, Khatami MR, Boroumand MA, Eshragian MR.

Iran J Kidney Dis. 2009 Jul;3(3):141-4.

2.
4.

Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.

Foody JM, Rathore SS, Galusha D, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM.

J Am Geriatr Soc. 2006 Mar;54(3):421-30.

5.

[Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices].

Skvrce NM, Bozina N, Sarinić VM, Tomić S.

Lijec Vjesn. 2010 Sep-Oct;132(9-10):277-82. Croatian.

PMID:
21261024
6.

Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.

Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L.

Exp Mol Pathol. 1993 Aug;59(1):51-7.

PMID:
8262165
7.
8.

[Hydroxymethylglutaryl CoA reductase inhibitors. A new group of substances for lowering a high cholesterol level].

Uhl D.

Med Monatsschr Pharm. 1988 Oct;11(10):326-30. German. No abstract available.

PMID:
3185357
9.

[Influence of protein biosynthesis inhibitors on the circadian rhythm of hydroxymethylglutaryl-CoA-reductase in the mouse liver].

Berndt J, Gaumert R, Löwel M.

Hoppe Seylers Z Physiol Chem. 1972 Oct;353(10):1503. German. No abstract available.

PMID:
4649769
Items per page

Supplemental Content

Write to the Help Desk